These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation. Mueller MM; Seifried E Transfus Clin Biol; 2006 Nov; 13(5):282-5; quiz 286-9. PubMed ID: 17196864 [TBL] [Abstract][Full Text] [Related]
4. [Pathogen reduction of blood components: from financial issues to possible long-term consequences]. Canellini G; Wasserfallen JB; Tissot JD Transfus Clin Biol; 2011 Aug; 18(4):493-7. PubMed ID: 21719339 [TBL] [Abstract][Full Text] [Related]
5. The risks associated with blood and blood product transfusion. Higgins C Br J Nurs; 2000 Dec 8-2001 Jan 10; 9(22):2281-90. PubMed ID: 12271194 [TBL] [Abstract][Full Text] [Related]
6. Immunological aspects of blood transfusions. Brand A Blood Rev; 2000 Sep; 14(3):130-44. PubMed ID: 10986149 [TBL] [Abstract][Full Text] [Related]
7. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Spinella PC Crit Care Med; 2008 Jul; 36(7 Suppl):S340-5. PubMed ID: 18594261 [TBL] [Abstract][Full Text] [Related]
8. Transfusion recipient epidemiology and outcomes research: possibilities for the future. Hillyer CD; Blumberg N; Glynn SA; Ness PM; Transfusion; 2008 Aug; 48(8):1530-7. PubMed ID: 18564389 [TBL] [Abstract][Full Text] [Related]
10. [Transfusion of blood and products derived from blood]. Wautier JL Rev Prat; 1999 Feb; 49(4):409-13. PubMed ID: 10319693 [No Abstract] [Full Text] [Related]
11. Ethical issues in transfusion medicine: the safety of blood and hematopoietic stem cell donation. Domen RE Curr Hematol Rep; 2005 Nov; 4(6):465-9. PubMed ID: 16232384 [TBL] [Abstract][Full Text] [Related]
13. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Josephson CD; Su LL; Hillyer KL; Hillyer CD Transfus Med Rev; 2007 Apr; 21(2):118-33. PubMed ID: 17397762 [TBL] [Abstract][Full Text] [Related]
14. Transfusion therapy in the emergency department. Labadie LL Emerg Med Clin North Am; 1993 May; 11(2):379-406. PubMed ID: 8491112 [TBL] [Abstract][Full Text] [Related]
15. Outpatient transfusion practice and factors leading to inpatient transfusion in a pediatric hematology/oncology program. Richardson M; Martel L; Martensson L J Pediatr Oncol Nurs; 2007; 24(1):46-51. PubMed ID: 17185402 [TBL] [Abstract][Full Text] [Related]
16. [The risk of substitution therapy with blood and blood products]. Baumgarten R Z Arztl Fortbild (Jena); 1994 Jan; 88(1):3-4. PubMed ID: 8154136 [No Abstract] [Full Text] [Related]
17. Transfusion support of hematology and oncology patients. The role of recombinant hematopoietic growth factors. Cottler-Fox M; Klein HG Arch Pathol Lab Med; 1994 Apr; 118(4):417-20. PubMed ID: 7909429 [TBL] [Abstract][Full Text] [Related]
18. [Blood transfusion and blood product risks and alternatives (from the civil law viewpoint of the judge)]. Schlund GH Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):M133-6. PubMed ID: 8001747 [No Abstract] [Full Text] [Related]
19. Clinicians as gatekeepers: what is the best route to optimal blood use? Isbister JP Dev Biol (Basel); 2007; 127():9-14. PubMed ID: 17486878 [TBL] [Abstract][Full Text] [Related]
20. Transfusion medicine and surgical practice. Valeri CR Bull Am Coll Surg; 1993 Sep; 78(9):19-24. PubMed ID: 10171511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]